Effect of Pancreaticoduodenectomy on the Course of Hepatic Steatosis

Background The progression of hepatic steatosis after pancreaticoduodenectomy (PD) is controversial. This study was designed to determine whether PD would influence the course of hepatic steatosis. Methods Patients admitted for PD and distal pancreatectomy (DP) from January 2004 to January 2008 were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgery 2010-09, Vol.34 (9), p.2122-2127
Hauptverfasser: Yu, Hsin-Hsien, Shan, Yan-Shen, Lin, Pin-Wen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The progression of hepatic steatosis after pancreaticoduodenectomy (PD) is controversial. This study was designed to determine whether PD would influence the course of hepatic steatosis. Methods Patients admitted for PD and distal pancreatectomy (DP) from January 2004 to January 2008 were enrolled. Exclusion criteria included liver metastasis, severe obesity (body mass index >30), diabetic mellitus, excessive alcohol consumption, and unavailable preoperative and 6-month postoperative unenhanced CT images. The pre-PD and post-PD liver attenuation, ratio, and difference of liver-to-spleen attenuation between liver and spleen attenuation were compared. Results Fifty patients who underwent PD and 20 patients who underwent DP were eligible. The mean follow-up period was 18.2 ± 1.6 months for the PD group and 19.7 ± 1.7 months for the DP group. Liver attenuation after PD was significantly decreased from 52.3 ± 1.1 H. to 47.6 ± 2 H. ( p  = 0.044), but no difference was observed in spleen attenuation. The liver-to-spleen attenuation ratio after PD also was significantly decreased: 1.12 ± 0.02 versus 1.01 ± 0.04 ( p  = 0.033). No difference in liver attenuation was found in the DP group. The female gender was a significant risk factor. Conclusions The liver attenuation of CT images decreases in patients who receive PD, which implicates that hepatic steatosis can develop after PD; however, the mechanism needs to be elucidated.
ISSN:0364-2313
1432-2323
DOI:10.1007/s00268-010-0636-8